Model for protecting mouse ulcerative colitis by antibacterial peptide C-BF
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- ZHEJIANG UNIV
- Publication Date
- 2014-09-10
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the field of biomedicine, and in particular relates to the protective effect of C-BF antimicrobial peptide on UC mice. Background technique
[0002] IBD is the abbreviation of inflammatory bowel disease, including ulcerative colitis and Crohn's disease, and its pathological mechanism is still unclear. IBD is defined as chronic relapsing gastrointestinal inflammation. Recent studies have shown that various immune, genetic and environmental factors affect the initiation and progression of colitis. The incidence of IBD is higher in Western countries, however, the incidence of IBD in other parts of the world is also increasing due to the influence of Western lifestyle. Ulcerative colitis is a chronic gastrointestinal disease associated with inflammation of the colonic mucosal surface. Human infection with ulcerative colitis may transform into the third most malignant tumor in humans—colorectal cancer.
[0003] There are two majo...